These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 6808441)
1. The unspecific antibody response to N. meningitidis group A capsular polysaccharide often seen in bacteraemic diseases. Käyhty H Parasite Immunol; 1982 May; 4(3):157-70. PubMed ID: 6808441 [TBL] [Abstract][Full Text] [Related]
2. Antibody response to capsular polysaccharides of groups A and C neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease. Käyhty H; Jousimies-Somer H; Peltola H; Mäketä PH J Infect Dis; 1981 Jan; 143(1):32-41. PubMed ID: 6783703 [TBL] [Abstract][Full Text] [Related]
3. Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974-March 1976). Parke JC; Schneerson R; Robbins JB; Schlesselman JJ J Infect Dis; 1977 Aug; 136 Suppl():S51-6. PubMed ID: 408433 [TBL] [Abstract][Full Text] [Related]
4. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388 [TBL] [Abstract][Full Text] [Related]
5. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development. Jennings HJ Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499 [No Abstract] [Full Text] [Related]
7. Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coli K92 in adult volunteers. Glode MP; Lewin EB; Sutton A; Le CT; Gotschlich EC; Robbins JB J Infect Dis; 1979 Jan; 139(1):52-9. PubMed ID: 108338 [TBL] [Abstract][Full Text] [Related]
8. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera. Dolan KT; Staub JM; Schofield TL; Ahonkhai VI; Ellis RW; Vella PP J Immunoassay; 1991; 12(4):543-64. PubMed ID: 1806588 [TBL] [Abstract][Full Text] [Related]
9. The immunogenicity of Hemophilus influenzae type B polysaccharide-Neisseria meningitidis group B outer membrane protein complex vaccine in infants and young children. Shapiro ED; Capobianco LA; Berg AT; Zitt MQ J Infect Dis; 1989 Dec; 160(6):1064-7. PubMed ID: 2511254 [TBL] [Abstract][Full Text] [Related]
10. Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein. Thiesen B; Greenwood B; Brieske N; Achtman M Vaccine; 1997 Feb; 15(2):209-19. PubMed ID: 9066040 [TBL] [Abstract][Full Text] [Related]
11. Increase in titers of antibodies to Mycoplasma pneumoniae in patients with purulent meningitis. Kleemola M; Käyhty H J Infect Dis; 1982 Aug; 146(2):284-8. PubMed ID: 6809846 [TBL] [Abstract][Full Text] [Related]
12. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation. Sood SK; Daum RS Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522 [TBL] [Abstract][Full Text] [Related]
13. Human immune responses to polysaccharide antigens: an analysis of bacterial polysaccharide vaccines in infants. Barrett DJ Adv Pediatr; 1985; 32():139-58. PubMed ID: 3909772 [TBL] [Abstract][Full Text] [Related]
14. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate). Gray BM Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521 [TBL] [Abstract][Full Text] [Related]
15. Immune response of infants and children to disseminated infections with Neisseria meningitidis. Griffiss JM; Brandt BL; Broud DD; Goroff DK; Baker CJ J Infect Dis; 1984 Jul; 150(1):71-9. PubMed ID: 6431015 [TBL] [Abstract][Full Text] [Related]
16. Conjugated polysaccharide vaccines. Ahmad H; Chapnick EK Infect Dis Clin North Am; 1999 Mar; 13(1):113-33, vii. PubMed ID: 10198795 [TBL] [Abstract][Full Text] [Related]
17. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy. Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941 [TBL] [Abstract][Full Text] [Related]
18. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. Mäkelä PH; Peltola H; Käyhty H; Jousimies H; Pettay O; Ruoslahti E; Sivonen A; Renkonen OV J Infect Dis; 1977 Aug; 136 Suppl():S43-50. PubMed ID: 408432 [No Abstract] [Full Text] [Related]
19. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis. Skevakis L; Frasch CE; Zahradnik JM; Dolin R J Infect Dis; 1984 Mar; 149(3):387-96. PubMed ID: 6425422 [TBL] [Abstract][Full Text] [Related]
20. Dose-related immunogenicity of Haemophilus influenzae type b capsular polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. Wong VK; Quagliata R; Adler R; Kim KS Am J Dis Child; 1991 Jul; 145(7):742-5. PubMed ID: 2058604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]